| Literature DB >> 35572869 |
Tianwang Guan1,2, Yuyan Wang3, Feng Li4, Dongting Chen4, Qingqian Wei4, Kenie Wang5, Hanbin Zhang4, Jinming Yang4, Jin Zeng4, Yanxian Lai2,6, Zhengxia Yang7, Cheng Liu2,6.
Abstract
Background: The influences of marital status on cardiovascular death risk in patients with breast cancer remained unclear. This study aimed to evaluate the associations of different marital status with cardiovascular death risk in patients with breast cancer.Entities:
Keywords: Breast cancer; Surveillance, Epidemiology, and End Results (SEER); cardio-oncology; cardiovascular death; marital status
Year: 2022 PMID: 35572869 PMCID: PMC9096314 DOI: 10.21037/jtd-21-1261
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895
Baseline characteristics before and after PSM
| Variables | Before PSM, N (%) | After PSM, N (%) | |||||
|---|---|---|---|---|---|---|---|
| Married | Unmarried | P | Married | Unmarried | P | ||
| N | 107,043 | 75,623 | 70,651 | 70,651 | |||
| Age at diagnosis | <0.001 | 0.970 | |||||
| 25–60 years | 61,453 (57.4) | 33,290 (44.0) | 33,073 (46.8) | 33,066 (46.8) | |||
| >60 years | 45,590 (42.6) | 42,333 (56.0) | 37,578 (53.2) | 37,585 (53.2) | |||
| Race | <0.001 | <0.001 | |||||
| White | 87,807 (82.0) | 57,037 (75.4) | 56,836 (80.4) | 53,779 (76.1) | |||
| Black | 7,486 (7.0) | 12,841 (17.0) | 11,601 (16.4) | 5,515 (7.8) | |||
| Other& | 11,750 (11.0) | 5745 (7.6) | 5,271 (7.5) | 8,300 (11.7) | |||
| Income* | <0.001 | 0.412 | |||||
| Low | 51,709 (48.3) | 40,042 (52.9) | 36,413 (51.5) | 36,567 (51.8) | |||
| High | 55,334 (51.7) | 35,581 (47.1) | 34,238 (48.5) | 34,084 (48.2) | |||
| Grade# | <0.001 | 0.096 | |||||
| Low | 71,224 (66.5) | 48,979 (64.8) | 46,318 (65.6) | 46,020 (65.1) | |||
| High | 35,819 (33.5) | 26,644 (35.2) | 24,333 (34.4) | 24,631 (34.9) | |||
| ER status | <0.001 | 0.028 | |||||
| Positive | 88,774 (82.9) | 61,909 (81.9) | 58,061 (82.2) | 57,744 (81.7) | |||
| Negative | 18,269 (17.1) | 13,714 (18.1) | 12,590 (17.8) | 12,907 (18.3) | |||
| PR status | <0.001 | 0.008 | |||||
| Positive | 78,232 (73.1) | 53,786 (71.1) | 50,822 (71.9) | 50,373 (71.3) | |||
| Negative | 28,811 (26.9) | 21,837 (28.9) | 19,829 (28.1) | 20,278 (28.7) | |||
| HER2 status | 0.001 | 0.441 | |||||
| Positive | 16,813 (15.7) | 11,464 (15.2) | 10,808 (15.3) | 10,704 (15.2) | |||
| Negative | 90,230 (84.3) | 64,159 (84.8) | 59,843 (84.7) | 59,947 (84.8) | |||
| AJCC stage | <0.001 | 0.136 | |||||
| I | 55,868 (52.2) | 35,212 (46.6) | 34,673 (49.1) | 34,462 (48.8) | |||
| II | 35,919 (33.6) | 26,335 (34.8) | 24,414 (34.2) | 24,136 (34.2) | |||
| III | 11,504 (10.7) | 9,693 (12.8) | 8,383 (11.9) | 8,658 (12.3) | |||
| IV | 3,752 (3.5) | 4,383 (5.8) | 3,451 (4.9) | 3,395 (4.8) | |||
| Surgery | <0.001 | 0.014 | |||||
| Yes | 102,342 (95.6) | 69,275 (91.6) | 66,210 (93.7) | 66,453 (94.1) | |||
| No evidence | 4,701 (4.0) | 6,348 (8.4) | 4,441 (6.3) | 4198 (5.9) | |||
| Chemotherapy | <0.001 | 0.833 | |||||
| Yes | 58,144 (54.3) | 45,706 (60.4) | 41,304 (58.5) | 41,265 (58.4) | |||
| No evidence | 48,899 (45.7) | 29,917 (39.6) | 29,347 (41.5) | 29,386 (41.6) | |||
| Radiotherapy | <0.001 | 0.953 | |||||
| Yes | 47,017 (43.9) | 38,047 (50.3) | 34,066 (48.2) | 34,055 (48.2) | |||
| No evidence | 60,026 (56.1) | 37,576 (49.7) | 36,585 (51.8) | 36,596 (51.8) | |||
&, other includes American Indian/Alaska Native and Asian/Pacific Islander; *, low (median household income was the worst 50% among all breast cancer patients) and high (median household income was the best 50%); #, low (Grade I: well-differentiated and Grade II: moderately differentiated) and high (Grade III: poorly differentiated and Grade IV: undifferentiated). PSM, propensity-score matching; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal receptor 2; AJCC, the American Joint Committee on Cancer.
Figure 1Cumulative incidence of cardiovascular death in marital status. (A) Univariate competing-risks regression analysis of cardiovascular death before PSM; (B) univariate competing-risks regression analysis of cardiovascular death after PSM. CVD, cardiovascular disease death; PSM, propensity score matching.
Multivariate competing-risks regression analysis of cardiovascular death
| Variables | Before PSM | After PSM | |||
|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||
| Unadjusted HR | |||||
| Married | Reference | Reference | |||
| Unmarried | 3.085 (2.831–3.361) | <0.001 | 2.012 (1.835–2.208) | <0.001 | |
| Model 1a | |||||
| Married | Reference | Reference | |||
| Unmarried | 2.043 (1.871–2.230) | <0.001 | 1.958 (1.785–2.148) | <0.001 | |
| Model 2b | |||||
| Married | Reference | Reference | |||
| Unmarried | 2.039 (1.867–2.226) | <0.001 | 1.954 (1.781–2.144) | <0.001 | |
| Model 3c | |||||
| Married | Reference | Reference | |||
| Unmarried | 1.971 (1.802–2.155) | <0.001 | 1.920 (1.748–2.107) | <0.001 | |
a, Model 1: HR was adjusted for statistically significant factors according to univariate analysis (age at diagnosis, income, grade, HER2 status, AJCC stage, chemotherapy and radiotherapy); b, Model 2: it was the same as Model 1, and also included ER status and PR status; c, Model 3: It is the same as Model 2, and also includes race and surgery. PSM, propensity-score matching; HR, hazard ratio; CI, confidence interval; HER2, human epidermal receptor 2; AJCC, the American Joint Committee on Cancer; ER, estrogen receptor; PR, progesterone receptor.
Univariate and multivariate competing-risks regression analysis base on different marital status of 182,173 patients
| Variables | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI)* | P value | ||
| Marital status | |||||
| Married | Reference | Reference | |||
| Single | 1.617 (1.420–1.842) | <0.001 | 1.623 (1.421–1.853) | <0.001 | |
| Separated | 0.711 (0.381–1.327) | 0.284 | 0.886 (0.474–1.658) | 0.705 | |
| Divorced | 1.712 (1.486–1.973) | <0.001 | 1.394 (1.209–1.608) | <0.001 | |
| Widowed | 6.208 (5.658–6.811) | <0.001 | 2.460 (2.227–2.717) | <0.001 | |
*, HR was adjusted for statistically significant factors according to univariate analysis (age at diagnosis, race, income, grade, HER2 status, AJCC stage, surgery, chemotherapy and radiotherapy). HR, hazard ratio; CI, confidence interval; HER2, human epidermal receptor 2; AJCC, the American Joint Committee on Cancer.
Figure 2Cumulative incidence of cardiovascular death in different marital status. CVD, cardiovascular disease death.